Subtype
Malignant Reproductive System Neoplasm
CI-CAN-00001172Explore in graph →
2,804 active trials38 approved drugs186 evidence items
- NCIt
- C36076
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001172Explore in graph →
Clinical trials
12,158 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,473)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00400348 | Safety and Efficacy Study of Panzem® Nanocrystal Colloidal Dispersion in Patients With Ovarian Cancer | completed | Phase 2 | 18 | CASI pharmaceuticals, Inc.INDUSTRY | 1 | Nov 25, 2008 | clinicaltrials |
| NCT00090376 | Evaluate the Effects of GPI 1485 on Erectile Function Following Bilateral Nerve-Sparing Prostatectomy | completed | Phase 2 | 240 | Eisai Inc.INDUSTRY | 1 | Nov 7, 2008 | clinicaltrials |
| NCT00753480 |
| A Study of D4064A Administered to Patients With Recurrent or Persistent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer |
| suspended |
| Phase 1 |
| 56 |
| Genentech, Inc.INDUSTRY |
| 1 |
| Nov 7, 2008 |
| clinicaltrials |
| NCT00089856 | GVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer | terminated | Phase 3 | 626 | Cell GenesysINDUSTRY | 8 | Nov 5, 2008 | clinicaltrials |
| NCT00772694 | Sorafenib Monotherapy in Inoperable/Recurrent Germ Cell Carcinoma Refractory to Chemotherapy(GCT) | unknown | Phase 2 | 20 | Fondation Wygrajmy ZdrowieOTHER | 1 | Oct 24, 2008 | clinicaltrials |
| NCT00777452 | A Prospective Longitudinal Study of Health-Related Quality of Life in Men With Clinically Localized Prostate Cancer | completed | — | 93 | Samsung Medical CenterOTHER | 1 | Oct 22, 2008 | clinicaltrials |
| NCT00007579 | To Explore Racial Differences in Potential Risk Factors for Developing Prostate Cancer in the VA Population. | completed | — | — | US Department of Veterans AffairsFED | 1 | Oct 17, 2008 | clinicaltrials |
| NCT00772798 | A Phase I/II Study of Paclitaxel Plus Carboplatin Plus Vorinostat in Recurrent Ovarian Cancer | unknown | Phase 2 | 70 | Herlev HospitalOTHER | 1 | Oct 15, 2008 | clinicaltrials |
| NCT00764166 | A Prospective Randomized Phase III Study Comparing Hormonal Therapy +/-Docetaxel(RisingPSA) | unknown | Phase 3 | 254 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Oct 1, 2008 | clinicaltrials |
| NCT00133224 | Docetaxel in Combination With GVAX ® Immunotherapy Versus Docetaxel and Prednisone in Prostate Cancer Patients | terminated | Phase 3 | 408 | Cell GenesysINDUSTRY | 10 | Sep 23, 2008 | clinicaltrials |
| NCT00104130 | Study of KOS-862 (Epothilone D) in Metastatic Prostate Cancer | terminated | Phase 2 | 53 | Bristol-Myers SquibbINDUSTRY | 1 | Sep 17, 2008 | clinicaltrials |
| NCT00425204 | Study for Patients Who Have Benefited and Tolerated Prior Panitumumab Treatment | completed | Phase 2 | 31 | AmgenINDUSTRY | 0 | Sep 15, 2008 | clinicaltrials |
| NCT00159328 | Efficacy Study of Magnetic Resonance (MR) Guided Focused Ultrasound in the Treatment of Large Fibroids | completed | Phase 4 | 50 | Imperial College LondonOTHER | 1 | Aug 13, 2008 | clinicaltrials |
| NCT00728871 | The Correlations Between HPV L1-Specific Immunologic Responses in Cervical Cancer and Cervical Intraepithelial Neoplasia (CIN) Patients and Their Prognosis | unknown | N/A | 600 | National Taiwan University HospitalOTHER | 1 | Aug 6, 2008 | clinicaltrials |
| NCT00199485 | Angelica Sinensis for the Treatment of Hot Flashes in Men Undergoing LHRH Therapy for Prostate Cancer | completed | Phase 4 | 44 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | Jul 29, 2008 | clinicaltrials |
| NCT00199537 | Bone Loss in Men on Androgen Blockade as Adjuvant Therapy for Prostate Cancer | completed | — | 25 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | Jul 29, 2008 | clinicaltrials |
| NCT00024414 | DHA-Paclitaxel in Treating Patients With Metastatic Prostate Cancer | unknown | Phase 2 | — | TheradexINDUSTRY | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00075543 | Docetaxel and Oxaliplatin in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer | unknown | Phase 1 / Phase 2 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00674349 | Screening of Biomarkers on Endometrial Cancers | unknown | N/A | 250 | National Taiwan University HospitalOTHER | 1 | Jul 22, 2008 | clinicaltrials |
| NCT00489060 | A Randomized Trial of External Beam Radiotherapy Versus Cryoablation in Patients With Localized Prostate Cancer | completed | Phase 3 | 244 | University of CalgaryOTHER | 1 | Jul 17, 2008 | clinicaltrials |
| NCT00338026 | A Phase I Study of ECO-4601 in Patients With Advanced Cancer | completed | Phase 1 | 26 | Thallion PharmaceuticalsINDUSTRY | 1 | Jul 15, 2008 | clinicaltrials |
| NCT00715286 | Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer (EOC): A Phase III Randomized Study | unknown | Phase 3 | 180 | All India Institute of Medical SciencesOTHER | 1 | Jul 15, 2008 | clinicaltrials |
| NCT00406939 | Vector Delivery of the IL-12 Gene in Men With Prostate Cancer | completed | Phase 1 | 4 | Baylor College of MedicineOTHER | 1 | Jul 10, 2008 | clinicaltrials |
| NCT00451945 | New Indications for Ultrasound in the Staging of Cervical Cancer | withdrawn | N/A | — | Rigshospitalet, DenmarkOTHER | 1 | Jun 18, 2008 | clinicaltrials |
| NCT00636259 | Casodex 150-mg Compassionate Use Trial for Subjects With Prostate Cancer | no longer available | — | — | AstraZenecaINDUSTRY | 0 | Jun 11, 2008 | clinicaltrials |
| NCT00173290 | Cytokine Regulation of Natural Killer Receptors in Inhibiting Activated T Cell Function | unknown | — | 200 | National Taiwan University HospitalOTHER | 1 | Jun 3, 2008 | clinicaltrials |
| NCT00150644 | A Study to Evaluate the Effects of Asoprisnil(J867) in Women With Uterine Fibroids Who Are Scheduled for a Hysterectomy | completed | Phase 2 | 33 | AbbottINDUSTRY | 0 | May 29, 2008 | clinicaltrials |
| NCT00152256 | A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating Women With Uterine Fibroids | completed | Phase 3 | 239 | AbbottINDUSTRY | 0 | May 29, 2008 | clinicaltrials |
| NCT00156208 | Safety of Treatment of Uterine Fibroids With Asoprisnil | completed | Phase 3 | 166 | AbbottINDUSTRY | 0 | May 29, 2008 | clinicaltrials |
| NCT00156156 | Study of Asoprisnil in the Treatment of Uterine Fibroids. | completed | Phase 3 | 149 | AbbottINDUSTRY | 0 | May 28, 2008 | clinicaltrials |
| NCT00548821 | Randomized Trial Between Weekly and 5 Day 3 Weekly Cisplatin for Cervical Cancer | unknown | Phase 3 | — | National University Hospital, SingaporeOTHER | 1 | May 15, 2008 | clinicaltrials |
| NCT00673192 | Evaluation of ELISA Assay on Human Papilloma Viruses (HPV) Infection Population | unknown | N/A | 100 | National Taiwan University HospitalOTHER | 1 | May 7, 2008 | clinicaltrials |
| NCT00087854 | Study of Individualized Amonafide to Treat Prostate Cancer | completed | Phase 1 / Phase 2 | 40 | Xanthus Pharmaceuticals, Inc.INDUSTRY | 1 | Apr 23, 2008 | clinicaltrials |
| NCT00655447 | Examining the Long-Term Risks of Oophorectomy | completed | — | 32,175 | Parker, William H., M.D.OTHER | 1 | Apr 9, 2008 | clinicaltrials |
| NCT00108290 | Chemotherapy, Hormone Therapy, and Surgery to Remove the Prostate Gland in Patients With High Risk Prostate Cancer | completed | Phase 2 | — | US Department of Veterans AffairsFED | 1 | Apr 4, 2008 | clinicaltrials |
| NCT00651222 | Influence of Hormone Therapy on Heart Attack Incidence in Men Undergoing Prostate Brachytherapy | completed | — | — | Prostate Cancer Foundation of ChicagoOTHER | 1 | Apr 2, 2008 | clinicaltrials |
| NCT00637208 | Sclerotherapy of Internal Spermatic Veins in Patients With Varicocele and Localized Prostate Cancer | completed | N/A | 10 | Maaynei Hayesha Medical CenterOTHER | 1 | Mar 17, 2008 | clinicaltrials |
| NCT00001302 | A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833 | completed | Phase 1 | 80 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001383 | A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833 | completed | Phase 1 | 52 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001944 | Vinorelbine and XR9576 to Treat Cancer | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00006155 | SU5416 and Carboplatin to Treat Ovarian Cancer | completed | Phase 1 | 33 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00022919 | Analysis of Prostate Cancer Short-Term Cultures Using Molecular Cytogenetic Methods | completed | — | 150 | National Human Genome Research Institute (NHGRI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00340717 | Markers for Early Detection of Prostate Cancer | completed | — | 100 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00278070 | Metronomic Oral Vinorelbine in Patients With Metastatic Tumors | completed | Phase 2 | — | Hellenic Cooperative Oncology GroupOTHER | 1 | Feb 29, 2008 | clinicaltrials |
| NCT00612495 | Endometrial Cancer - LOHP Alone and With 5FU | completed | Phase 2 | 31 | SanofiINDUSTRY | 1 | Feb 11, 2008 | clinicaltrials |
| NCT00405574 | Study of ATN-224 in Patients With Prostate Cancer | unknown | Phase 2 | 50 | AttenuonINDUSTRY | 1 | Jan 30, 2008 | clinicaltrials |
| NCT00076531 | Clinical Trial for Prostate Cancer | completed | Phase 3 | — | Oakwood Laboratories, LLCINDUSTRY | 0 | Jan 28, 2008 | clinicaltrials |
| NCT00590213 | Compare the Value of Prophylactic Versus Therapeutic Breast Radiotherapy in CASODEX(COMART) | completed | Phase 4 | 125 | AstraZenecaINDUSTRY | 1 | Jan 25, 2008 | clinicaltrials |
| NCT00072930 | MEDI-522 in the Treatment of Patients With Metastatic Androgen-Independent Prostate Cancer | completed | Phase 2 | 150 | MedImmune LLCINDUSTRY | 7 | Jan 15, 2008 | clinicaltrials |
| NCT00591656 | Systemic Consolidation Therapy After Primary Chemoradiation Therapy for Locally Advanced Cervical Cancer | unknown | — | 69 | Seoul National University HospitalOTHER | 1 | Jan 11, 2008 | clinicaltrials |
Data updated 24 days agoSource updated Nov 25, 2008source: clinicaltrials